MYCN and neuroblastoma: Germline gain-of-function point mutations are observed in half of hereditary NB and in 9% of the sporadic forms [170], and correlate with high risk and poor prognosis [171,172], mainly because both the wildtype and mutant forms of ALK induce MYCN transcription and potentiate its oncogenic activity in this tumor type [173].